Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AMG, Amgen, analytical, anniversary, antitrust, BGC, bid, bidder, bioreactor, blinatumomab, BLINCYTO, BPG, built, Canada, carfilzomib, chapter, CIP, consummated, CTA, customary, cut, DAL, denosumab, esophageal, ESP, gastric, GSP, landscape, largest, LOI, lowest, MAA, MAH, nationwide, Paper, PDUFA, pharmacovigilance, pioneered, pledged, procured, procurement, prominent, reaction, rolled, scheme, Seattle, seminar, SL, society, sponsorship, stake, substandard, trace, track, translation, UK, ULC, undefined, User, waiting, win, windfall, winner, XGEVA
Removed:
benchmarking, discrete, functional, repayable, solid, Zealand
Filing tables
Filing exhibits
Related press release
ONC similar filings
Filing view
External links